Short Course of Antifungal Therapy in Patients With Uncomplicated Candida Bloodstream Infection: Another Case of Less Is More in the Clinical Setting?
Open Access
- 8 December 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 10 (1) , ofac656
Abstract
To compare the clinical outcomes of patients receiving short course (SC) or prolonged course (PC) of antifungal therapy for uncomplicated Candida bloodstream infections (BSI). All episodes of uncomplicated Candida BSI from 1 September 2018 to 31 August 2020 were reviewed. We compared the primary (all cause 90-day mortality) and secondary study endpoints (1-year recurrent Candida BSI and all-cause 1-year-mortality) among patients who underwent SC (5-11 days) or PC (12-24 days) therapy using propensity score analysis with the inverse probability of treatment weighting (IPTW) method. A total of 114 patients with uncomplicated Candida BSI were included: 35 (30.7%) were classified into the SC-group [median of 9 days (IQR 7-11 days)] and 79 (69.3%) into the PC-group [median of 14 days (IQR 14-16 days)]. Patients in SC-group compared to PC-group had a higher rate of hospitalization in the surgical ward (40.0% vs 19.0%, p = 0.02), or septic shock at the time of Candida BSI onset (11.4% vs 1.3%; p = 0.03). The risk of 90 day-mortality was not different between SC and PC groups [n = 8 (22.9%) vs 17 (21.5%), respectively; IPTW-adjusted sHR = 0.67; 95% CI = 0.31-1.47, P = 0.20]. The risk for recurrent Candida BSI within 1 year of completing therapy (IPTW-adjusted sHR = 1.07; 95% CI = 0.20-5.80, p = 0.94) or for all cause 1-year mortality (IPTW-adjusted HR = 0.72; 95% CI = 0.35-1.50, p = 0.38) did not differ between groups. Short or prolonged course of antifungal therapy do not affect mortality and BSI recurrence in patients with uncomplicated candidemia.Keywords
This publication has 37 references indexed in Scilit:
- Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patientsClinical Microbiology and Infection, 2012
- Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2009
- A Multicenter, Double‐Blind Trial of a High‐Dose Caspofungin Treatment Regimen versus a Standard Caspofungin Treatment Regimen for Adult Patients with Invasive CandidiasisClinical Infectious Diseases, 2009
- Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive CandidiasisClinical Infectious Diseases, 2007
- Impact of early central venous catheter removal on outcome in patients with candidaemiaClinical Microbiology and Infection, 2007
- Anidulafungin versus Fluconazole for Invasive CandidiasisNew England Journal of Medicine, 2007
- Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trialThe Lancet, 2007
- Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance StudyClinical Infectious Diseases, 2004
- A Pilot Study of the Management of Uncomplicated Candidemia with a Standardized Protocol of Amphotericin BClinical Infectious Diseases, 1999
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987